The 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands, 13–16 June 2019, saw hematology experts from around the globe congregate for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more were showcased across the specturm of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

EHA 2019

24th Congress of the European Hematology Association
Amsterdam, 13–16 June 2019

EHA 2019

24th Congress of the European Hematology Association
Amsterdam, 13–16 June 2019

The 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands, 13–16 June 2019, saw hematology experts from around the globe congregate for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more were showcased across the specturm of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos